RELATIONSHIP OF THE T-REGULATORY CELLS NUMBER WITH THE CYTOTOXIC T-LYMPHOCYTES AND NKT-CELLS LEVELS IN PATIENTS WITH RENAL CANCER

2017 ◽  
Vol 63 (1) ◽  
pp. 104-109
Author(s):  
Andrey Savchenko ◽  
Aleksandr Borisov ◽  
Igor Kudryavtsev ◽  
Anton Moshev

The aim of the study was to investigate the features of the relation to the number and the phenotype of the cytotoxic T-lymphocytes and NKT-cell from regulatory T-cells content in the blood by patients with renal cell carcinoma. The study included patients with renal cell carcinoma (T3N0M0, clear cell type) at the age of 40-55 years before surgery. Lymphocyte immunophenotyping was performed by flow cytometry. It is found that in the peripheral blood of the patients with renal cell carcinoma accompanied by increased number of T-regulatory cells observed decrease content of the cytotoxic T-lymphocytes and increased levels of the NKT-cells. It is assumed that no change in the number of activated T-regulatory cells and cytotoxic T-lymphocyte determined migration from the blood. Increasing the amount of the NKT-cells in renal cancer is determined by the increase of activated and effector cells but at lower levels of the regulatory subpopulation. The content of the T-regulatory cells in healthy people weakly correlated with the effector subpopulations of T-lymphocytes. In patients with renal cancer the number of the activated T-regulatory cells is closely correlated with the various NKT-lymphocytes fractions. Moreover, if the mature and regulatory NKT-cells subset detected negative relations, so with the NKT-cells expressing CD28 and CD57 markers found positive correlations that characterizes the codirectional dynamics the activated of the regulatory and effector T-lymphocyte subpopulations levels in the background of tumor growth. A canonical analysis demonstrated that the highest significance kidney cancer patients have activated regulatory T-cells, cytotoxic T cells and NKT-cells. A canonical analysis demonstrated that the highest significance by renal cancer patients have activated regulatory T-cells, cytotoxic T-cells and NKT-cells.

PLoS ONE ◽  
2012 ◽  
Vol 7 (10) ◽  
pp. e46600 ◽  
Author(s):  
Adrian Schwarzer ◽  
Benita Wolf ◽  
Jan L. Fisher ◽  
Thomas Schwaab ◽  
Sven Olek ◽  
...  

Author(s):  
Anne M. Pesenacker ◽  
Lucy R. Wedderburn

In recent years, there have been many new developments in the field of regulatory T cells (Treg), challenging the consensus on their behaviour, classification and role(s) in disease. The role Treg might play in autoimmune disease appears to be more complex than previously thought. Here, we discuss the current knowledge of regulatory T cells through animal and human research and illustrate the recent developments in childhood autoimmune arthritis (juvenile idiopathic arthritis (JIA)). Furthermore, this review summarises our understanding of the fields and assesses current and future implications for Treg in the treatment of JIA.


PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e37513 ◽  
Author(s):  
Yang Lili ◽  
Wei Yi ◽  
Yang Ji ◽  
Sun Yue ◽  
Shi Weimin ◽  
...  

2020 ◽  
Vol 20 ◽  
pp. 62-71
Author(s):  
Sabina Davidsson ◽  
Michelangelo Fiorentino ◽  
Francesca Giunchi ◽  
Margareta Eriksson ◽  
Ann Erlandsson ◽  
...  

2018 ◽  
Vol 185 (2) ◽  
pp. 357-360 ◽  
Author(s):  
Angela Giovazzino ◽  
Stefania Leone ◽  
Valentina Rubino ◽  
Anna Teresa Palatucci ◽  
Giuseppe Cerciello ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (7) ◽  
pp. 2217-2218
Author(s):  
Jerzy W. Kupiec-Weglinski

The OX40 T-cell costimulatory molecule, critical for both survival and proliferation of activated T cells, has now been identified as a key negative regulator of Foxp3+ T regulatory cells (Tregs).


Sign in / Sign up

Export Citation Format

Share Document